Anmelden
Cover von Business Of Biotech

Wirtschaft

Business Of Biotech

von Ben Comer

Website RSS

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.

Folgen

  1. Translating A New Discovery Into A Novel Cancer Therapy With Grid Therapeutics' Ned Patz, M.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Edward (Ned) Patz, M.D., Cofounder and CEO at Grid Therapeutics, explains how a Duke

  2. Bioprinting 3D Human Tissue To Discover And Test New Treatments With Viscient Bio's Keith Murphy

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Keith Murphy, CEO at Viscient Biosciences, unpacks how 3D human tissue models and sc

  3. Investing In Tomorrow's CNS Breakthroughs With Breyer Capital's Bret Bostwick, M.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Bret Bostwick, M.D., Venture Partner at Breyer Capital, a family office, talks about

  4. AI, China, And Biotech Investing With SR One's Simeon George, M.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Simeon George, M.D., Cofounder and CEO at SR One Capital Management, returns to the

  5. Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Cyriac Roeding talks about cofounding and leading Earli, a "bioAI" company using syn

  6. Growing And Scaling A Radiopharmaceuticals Company With AdvanCell's Philina Lee, Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Philina Lee, Ph.D., CEO at AdvanCell, explains how lead-based targeted alpha therapi

  7. Finding New Opportunities In Obesity With Moonwalk Bioscience's Alex Aravanis, M.D., Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Alex Aravanis, M.D., Ph.D., CEO of Moonwalk Biosciences, talks about the opportunity

  8. Biotech Finance And Investor Update With Independent Board Director Allan Shaw

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Independent Board Director and five-time public company CFO Alan Shaw returns to the

  9. Funding A Virtual Biotech Without Institutional Capital With Sarcomatrix's David Craig

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, David Craig, Cofounder, President, and CEO at Sarcomatrix, explains why the old biot

  10. Picking Biotech Winners Beyond The Hype Cycle With Andera Partners' Olivier Litzka

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Olivier Litzka, Partner at Andera Partners, talks about what it really takes for bio

  11. Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Omar Khalil, Managing Director at Santé Ventures, describes forming and funding star

  12. Getting To A First Product Approval With Celcuity's Brian Sullivan

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Brian Sullivan, CEO at Celcuity, talks about winning the company's first FDA approva

  13. Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Paul Hastings, Founding CEO and Board Member at Nkarta, an allogeneic cell therapy d

  14. A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Annette Bakker, Ph.D., CEO at the Children's Tumor Foundation, and Andrew Lo, Ph.D.,

  15. Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Aris Baras, M.D., SVP, Head of Regeneron Genetics Center (RGC) and Co-Head of Regene

  16. Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Matt Winton, Ph.D., Chief Commercial and Business Officer at CervoMed, talks about p

  17. BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On the Business of Biotech this week, industry veteran Dr. Jeremy Levin, Founder, Chairman, and former CEO at Ovid Therapeutics, sits d

  18. BoB@BIO: Biotech Investing And Deals With Sofinnova's Maha Radhakrishnan, M.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) This week's episode of the Business of Biotech was recorded at the BIO Convention in San Diego, where guest Maha Radhakrishnan, M.D., E

  19. Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Al Sandrock, M.D., Ph.D., President and CEO at Voyager Therapeutics, talks about why

  20. Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, William Ho, CEO of IN8bio, explains why gamma delta T cells may have an edge against

  21. Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, William Soliman, Founder and CEO of the Accreditation Council for Medical Affairs (A

  22. The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Tyler Menichiello, chief editor at Bioprocess Online, host of the Better Biopharma p

  23. Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Jeff Jonas, M.D., CEO of Tortugas Neuroscience, talks about the company's April 2026

  24. Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Neil McFarlane, CEO at Zevra Therapeutics, talks about transitioning to a focused ra

  25. Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Marinna Madrid, Ph.D., Cofounder, Board Member, Chief Product and Regulatory Officer

  26. Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Wyatt McDonnell, Ph.D., cofounder and CEO at Infinimmune, talks about how single-cel

  27. From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Brett Monia, Ph.D., CEO at Ionis Pharmaceuticals, talks about how antisense oligonuc

  28. Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, we talk with NervGen leaders Adam Rogers, M.D., and Rich Macary about NVG-291, a dai

  29. The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, five-time public company CFO and seven-time public company board member Allan Shaw t

  30. Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.

    We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, we speak with Dr. Sarfaraz Niazi, Ph.D., about how biosimilar regulations have taken

Ältere Folgen

Anmelden oder registrieren

Jetzt

0:00 / 0:00